and suspended in blocking solution containing cold PBS supplemented with 0.5%
bovine serum albumin (BSA). The cells were treated with rat Fc block (CD32,
Cat#550271; BD Biosciences, San Jose, CA, USA) for 20 minutes before incubation
with antibodies. The following antibodies conjugated with fluorescein
isothiocyanate (FITC), phycoerythrin (PE), or biotin were used: CD29 (clone
Ha2/5, Cat#555005, dilution 1:50; BD Biosciences), CD90-1 (clone OX-7,
Cat#551401, dilution 1:25; BD Biosciences), CD45 (clone 30-F11, Cat#553077,
dilution 1:50; BD Biosciences), and CD34 (clone RAM34, Cat#551387, dilution
1:50; BD Biosciences). The corresponding isotypes (BD Biosciences) were used as
nonspecific binding controls. After incubation at 4ºC for 20 minutes, the cells
were washed with PBS/0.5% BSA, centrifuged at 300 xg for 5 minutes, and
suspended in PBS for data acquisition. DAPI 0.1 µg/mL (Cat# D9452,
Sigma-Aldrich) was added to exclude dead cells. The samples were acquired in a
BD FACSAria II flow cytometer (BD Biosciences) and the resulting data were
analyzed using the software FlowJo, version 10.1.